EUDRAGIT® for Controlled Release Oral Drugs

EUDRAGIT® for Controlled Release Oral Drugs
Product Description

Poly(meth)acrylates for controlled-, immediate- and delayed-release oral solid dosage forms. Get in contact with us for customized polymers.

Evonik Corporation

  • US
  • 2017
    On CPHI since
  • 1
    Certificates
Company types
Manufacturer/Innovator

Evonik Corporation

  • US
  • 2017
    On CPHI since
  • 1
    Certificates
Company types
Manufacturer/Innovator

More Products from Evonik Corporation (4)

  • Specialized Parenteral Drug Services

    Product Specialized Parenteral Drug Services

    Meeting the parenteral drug delivery challenge with Evonik. Polymer-based parenteral formulations taking extended release and targeted release further – advanced parenterals from small molecules to biopharmaceuticals - all bases covered.  Lipid nanoparticle drug delivery technologies for oligonucl...
  • Exclusive Synthesis of APIs and Intermediates

    Product Exclusive Synthesis of APIs and Intermediates

    Proprietary and custom advanced intermediates and APIs.  CMO for APIs from the clinical stage through commercialization.  Specific expertise in highly potent active pharmaceutical ingredients (HPAPIs), microbial fermentation, continuous processing and more.
  • RESOMER® Bioresorbable Polymers

    Product RESOMER® Bioresorbable Polymers

    Bioresorbable polymers for controlled release depot injections & medical device applications.  Get in contact with us for customized polymers.
  • EUDRATEC® Oral Drug Formulation Technologies

    Product EUDRATEC® Oral Drug Formulation Technologies

    EUDRATEC® technologies offer a broad range of innovative drug delivery technologies. EUDRATEC® ADD toolbox is comprised of different formulation concepts to prevent alcohol-induced dose dumping EUDRATEC® PEP provides an opportunity for attractive IP-protected life-cyc...